ArticleCureus2025
Vitamin D Status and Its Association With Disease Severity in Hashimoto's Thyroiditis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Immunopathogenesis, Diagnosis, and Treatment of Hashimoto's Thyroiditis.Archives of internal medicine research · 2026Article
- Vitamin D and gut microbiota in thyroid diseases: mechanisms and therapeutic potential.Frontiers in immunology · 2026Review
- Sexual Functioning and Depressive Symptoms in Levothyroxine-Treated Women with Postpartum Thyroiditis and Different Vitamin D Status.Nutrients · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Hashimoto's thyroiditis (HT), the most common autoimmune thyroid disorder, involves chronic lymphocytic infiltration and thyroid dysfunction. Vitamin D deficiency has been linked to autoimmune thyroid diseases, suggesting an immunomodulatory role. This study examines the association between serum vitamin D levels and HT severity in patients at a secondary-level hospital in Mexico. Methods A retrospective observational study was conducted on adult patients diagnosed with HT from January 2022 to January 2024. Clinical and laboratory data, including serum 25-hydroxyvitamin D (25(OH)D), thyroid-stimulating hormone (TSH), free thyroxine (FT4), and anti-thyroid peroxidase (anti-TPO) antibodies, were collected. Patients were classified by thyroid function and vitamin D status. Statistical analyses were performed to evaluate correlations and group associations to determine the relationship between vitamin D deficiency and HT severity. Results A total of 114 patients were included in the study: 1.8% (n=2) were classified as euthyroid, 18.4% (n=21) as having subclinical hypothyroidism, and 79.8% (n=91) as having overt hypothyroidism. Vitamin D deficiency, defined as serum 25(OH)D levels below 20 ng/mL, was highly prevalent, affecting 49.5% (n=45) of patients with overt hypothyroidism and 42.9% (n=9) of those with subclinical hypothyroidism. A significant inverse correlation was observed between 25(OH)D levels and anti-TPO antibody titers (p=0.01), suggesting an association between lower vitamin D concentrations and increased autoimmune activity. Additionally, vitamin D-deficient patients exhibited significantly higher TSH levels compared to those with sufficient vitamin D (p=0.01). No significant differences were found in FT4 levels across the different vitamin D categories. Conclusions This study suggests an inverse correlation between vitamin D deficiency and the severity of HT, supporting the potential immunomodulatory role of vitamin D. However, due to the observational nature of the study, causal relationships cannot be inferred. Given the high prevalence of vitamin D deficiency among patients with HT, further research is warranted to explore the therapeutic implications of vitamin D supplementation on disease progression and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.